These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 12901348

  • 1. Critical review of pathogenetic mechanisms in myelofibrosis with myeloid metaplasia.
    Martyré MC.
    Curr Hematol Rep; 2003 May; 2(3):257-63. PubMed ID: 12901348
    [Abstract] [Full Text] [Related]

  • 2. Stem cell dysregulation in myelofibrosis with myeloid metaplasia: current data on growth factor and transcription factor involvement.
    Martyré MC, Le Bousse-Kerdilès MC, members of the French INSERM Research Network on Myelofibrosis With Myeloid Metaplasia.
    Semin Oncol; 2005 Aug; 32(4):373-9. PubMed ID: 16202683
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis of myelofibrosis with myeloid metaplasia.
    Tefferi A.
    J Clin Oncol; 2005 Nov 20; 23(33):8520-30. PubMed ID: 16293880
    [Abstract] [Full Text] [Related]

  • 4. Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options.
    Mesa RA, Barosi G, Cervantes F, Reilly JT, Tefferi A.
    Best Pract Res Clin Haematol; 2006 Nov 20; 19(3):495-517. PubMed ID: 16781486
    [Abstract] [Full Text] [Related]

  • 5. RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia.
    Jones LC, Tefferi A, Idos GE, Kumagai T, Hofmann WK, Koeffler HP.
    Oncogene; 2004 Oct 14; 23(47):7846-53. PubMed ID: 15361842
    [Abstract] [Full Text] [Related]

  • 6. New approaches in the treatment of myelofibrosis.
    Hennessy BT, Thomas DA, Giles FJ, Kantarjian H, Verstovsek S.
    Cancer; 2005 Jan 01; 103(1):32-43. PubMed ID: 15565565
    [Abstract] [Full Text] [Related]

  • 7. Myelofibrosis with myeloid metaplasia with fatty bone marrow: report of a new case.
    Gerli GC, Gianelli U, Carraro MC, Bestetti A, Marchetti M, Barosi G.
    Haematologica; 2001 Aug 01; 86(8):885-6. PubMed ID: 11524257
    [No Abstract] [Full Text] [Related]

  • 8. [Agnogenic myeloid metaplasia. Etiology and pathogenesis].
    Gutiérrez Martín M, Gómez Casal F.
    Rev Clin Esp; 1983 Apr 30; 169(2):77-82. PubMed ID: 6348893
    [No Abstract] [Full Text] [Related]

  • 9. [Idiopathic myelofibrosis. Main pathogenetic, prognostic and therapeutic aspects].
    Barulli S, Rupoli S, Cinciripini A, Scortechini AR, Cantori I, Leoni P.
    Recenti Prog Med; 1995 Apr 30; 86(7-8):312-9. PubMed ID: 7569290
    [Abstract] [Full Text] [Related]

  • 10. New insights into the pathogenesis and drug treatment of myelofibrosis.
    Tefferi A.
    Curr Opin Hematol; 2006 Mar 30; 13(2):87-92. PubMed ID: 16456374
    [Abstract] [Full Text] [Related]

  • 11. Current perspective in agnogenic myeloid metaplasia.
    Tefferi A, Silverstein MN.
    Leuk Lymphoma; 1996 Sep 30; 22 Suppl 1():169-71. PubMed ID: 8951788
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment?
    Hasselbalch HC.
    Leuk Res; 2009 Jan 30; 33(1):11-8. PubMed ID: 18632152
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Splenic extramedullary hematopoiesis in myelofibrosis. Pathogenetic considerations apropos of a personally studied case].
    Piaserico PL, Piaserico GP.
    Minerva Med; 1983 Oct 13; 74(39):2313-8. PubMed ID: 6657100
    [Abstract] [Full Text] [Related]

  • 16. A review of myelofibrosis in dogs.
    Reagan WJ.
    Toxicol Pathol; 1993 Oct 13; 21(2):164-9. PubMed ID: 8210938
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia.
    Reilly JT.
    Semin Oncol; 2005 Aug 13; 32(4):359-64. PubMed ID: 16202681
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Idiopathic myelofibrosis with extramedullary hematopoiesis in the kidneys.
    Schnuelle P, Waldherr R, Lehmann KJ, Woenckhaus J, Back W, Niemir Z, van der Woude FJ.
    Clin Nephrol; 1999 Oct 13; 52(4):256-62. PubMed ID: 10543329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.